Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02132741

Optical Coherence Tomography And NEphropathy: The OCTANE Study

Assessment of Retinal Vasculature Using Optical Coherence Tomography in Health, Hypertension & Chronic Kidney Disease.

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
University of Edinburgh · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Patients with high blood pressure (hypertension) and chronic kidney disease are at an increased risk of developing heart disease and strokes. Part of this risk is due to changes in the structure and function of the blood vessels throughout the body. It is thought that reducing high blood pressure and treating chronic kidney disease improves the structure and function of blood vessels but information on this is limited. Optical coherence tomography (OCT) is a method of looking at the blood vessels at the back of the eye. It is a simple, quick and non-invasive test that you may have previously had during a visit to the optician. The purpose of the study is to ascertain whether OCT is able to detect changes in the eye's blood vessels in patients with hypertension and chronic kidney disease compared to healthy individuals and also to see if any differences seen improve with treatment.

Detailed description

This project is an exploratory study, using enhanced depth imaging with the new SPECTRALIS OCT, designed to examine choroidal and microvascular retinal structure in patients with hypertension, chronic kidney disease (CKD), and in age and sex matched healthy controls. The study is non-invasive and takes only a few seconds to acquire these complex images. The Centre, where the images will be captured and where image analysis systems are located, is on the Royal Infirmary of Edinburgh (RIE) site close to the RIE outpatient clinics, making recruitment easy.

Conditions

Timeline

Start date
2014-05-16
Primary completion
2027-12-31
Completion
2028-09-01
First posted
2014-05-07
Last updated
2025-05-07

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02132741. Inclusion in this directory is not an endorsement.

Optical Coherence Tomography And NEphropathy: The OCTANE Study (NCT02132741) · Clinical Trials Directory